Urinary Tract Infection Market Research Report—Forecast till 2027
Global Urinary Tract Infections Market is anticipated to exhibit a CAGR of 3.62% during the review period of 2020 to 2027. The infection in urinary system parts such as kidneys, ureters, bladder, and urethra are referred to as urinary tract infection. The major causes of UTI infection are unsafe sex, lack of hygiene, and diabetes.
Global Urinary Tract Infections Market is expected to register the highest market growth owing to the largest market value of USD 9,490.88 Million in 2019. As per the World Health Organization, 1 million hospitalizations of women occur each year due to UTIs, which affect almost half the female population around the world. Urological health issues are more common in diabetic patients. An increasing prevalence of diabetic population is expected to boost the global UTI patients worldwide. However, complex regulatory requirements are anticipated to restrain the growth of the global urinary tract infection market during the review period.
Global Urinary Tract Infections Market has been segmented into Drug Class, Application, Pathogen, End User.
In terms of drug class, the market has been classified into quinolones, β-lactam & cephalosporins, aminoglycosides, penicillin, and azoles. The quinolones segment is further sub-divided into ciprofloxacin, enoxacin, norfloxacin, ofloxacin, pefloxacin, and fleroxacin. The cephalosporin is again classified into avycaz, cedax, cefdinir, and cefditoren. The β-lactam is further divided into amoxicillin-clavulanate, cefdinir, cefaclor, and cefpodoxime-proxetil.
The Global Urinary Tract Infections Market, based on application, has been divided into urethritis, cystitis, and pyelonephritis. In terms of the pathogen, the market has been categorized into Escherichia coli, Staphylococcus saprophyticus, Klebsiella pneumoniae, Proteus mirabilis, and Enterococcus faecalis. By end-user category, the global urinary tract infections market has been classified into hospitals, clinics, self-administered, and others.
Geographically, the global UTI market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to dominate the global market owing to the largest market share of 33.6% of the global market in 2019. The regional market growth is driven by the presence of key manufacturers, the increasing prevalence of urinary tract infections, and the increasing aging woman population in the region. The market in the Americas is categorized into North America and Latin America. Additionally, the global market growth is driven by the increasing technological advancements in diagnostics and therapeutic products coupled with the rising prevalence of urinary tract diseases and other kidney problems.
Europe is expected to register the second-largest market of the Global Urinary Tract Infection. The regional market is segmented into France, Germany, Italy, Spain, and the UK. The regional market growth is attributed to the increasing awareness of urinary tract diseases, increasing educational activity, and the availability of different diagnostic and therapeutic methods to manage the infection. Asia-Pacific is set to exhibit the fastest-growing market for UTI during the review period. The regional market growth is driven by the developing economies and highly populated countries such as China, India, and South Korea.
The Prominent Players in the Global Urinary Tract Infections Market are Pfizer Inc., Novo Nordisk A/S, Novartis Ag, Merck & Co., Inc., Eli Lily and Company, Allergan, Cipla Inc., Teva Pharmaceuticals, GlaxoSmithKline plc, and Bayer AG.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.